IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder (Q39173839)

9 September 2017

title

IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder (English)

1 reference

9 September 2017

1 reference

Peir-In Liang

1

1 reference

9 September 2017

Yu-Hui Wang

2

1 reference

9 September 2017

Ting-Feng Wu

3

1 reference

9 September 2017

Wen-Ren Wu

4

1 reference

9 September 2017

Alex C Liao

5

1 reference

9 September 2017

Kun-Hung Shen

6

1 reference

9 September 2017

Chung-Hsi Hsing

7

1 reference

9 September 2017

Yow-Ling Shiue

8

1 reference

9 September 2017

Hsuan-Ying Huang

9

1 reference

9 September 2017

Han-Ping Hsu

10

1 reference

9 September 2017

Li-Tzon Chen

11

1 reference

9 September 2017

Ching-Yih Lin

12

1 reference

9 September 2017

Chein Tai

13

1 reference

9 September 2017

Jui-Yu Wu

14

1 reference

9 September 2017

Chien-Feng Li

15

1 reference

9 September 2017

language of work or name

English

0 references

publication date

28 March 2013

1 reference

Journal of Clinical Pathology

9 September 2017

published in

1 reference

9 September 2017

volume

66

1 reference

9 September 2017

issue

7

1 reference

9 September 2017

page(s)

573-582

1 reference

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

IGF-I receptor signalling in transformation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Signalling through IGF-I and insulin receptors: where is the specificity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

IGFBP5 induces cell adhesion, increases cell survival and inhibits cell migration in MCF-7 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

Behavior of Urothelial Carcinoma With Respect to Anatomical Location

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2012-201278

10.1136/JCLINPATH-2012-201278

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference